<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02473965</url>
  </required_header>
  <id_info>
    <org_study_id>GTI1306</org_study_id>
    <nct_id>NCT02473965</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis</brief_title>
  <official_title>A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grifols Therapeutics LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Grifols Therapeutics LLC</source>
  <brief_summary>
    <textblock>
      This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the
      efficacy and safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified
      (IGIV-C) as a corticosteroid (CS)-sparing agent in subjects with CS-dependent Myasthenia
      Gravis (MG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study consists of 2 phases: IGIV-C Run-in Phase and Corticosteroid Tapering/IGIV-C
      Maintenance Phase.

      In the Run-in Phase, subjects will receive a total of 3 doses of IGIV-C (1 loading dose of 2
      g/kg and 2 maintenance doses of 1 g/kg) while maintaining a stable dose of corticosteroids.

      In the CS Tapering/IGIV-C Maintenance Phase, subjects will continue 1 g/kg IGIV-C and begin a
      prescribed CS tapering regimen where the CS dose is decreased every 3 weeks.

      Approximately 60 subjects are planned to be enrolled in the study across multiple centers in
      North America and Europe. The total duration of study participation for each subject is up to
      45 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of subjects achieving a 50% or greater reduction in corticosteroid dose</measure>
    <time_frame>From baseline to Week 39</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Myasthenia Gravis</condition>
  <arm_group>
    <arm_group_label>IGIV-C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An IGIV-C loading dose of 2 g/kg and maintenance dose of 1 g/kg will be administered in CS dependent subjects with MG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% sodium chloride injection, USP or equivalent</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IGIV-C</intervention_name>
    <description>Run-Phase: 1 loading dose of 2 g/kg IGIV-C and 2 maintenance doses of 1 g/kg IGIV-C
Corticosteroid Tapering/IGIV-C Maintenance Phase: 1 g/kg IGIV-C every 3 weeks for up to 36 weeks</description>
    <arm_group_label>IGIV-C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Anti-acetylcholine receptor antibody positive

          -  Confirmed diagnosis of generalized MG historically meeting the clinical criteria for
             diagnosis of MG defined by the Myasthenia Gravis Foundation of America classification
             of Class II, III, IV, or V historically

          -  At Screening, subjects may have symptoms controlled by CS. Subjects who only have a
             history of ocular MG may not enroll.

          -  On systemic CS for a minimum period of at least 3 months and on a stable CS dose of
             &gt;=15 mg/day and &lt;=60 mg/day (prednisone equivalent) for the month prior to Screening.

          -  At least 1 previous completed attempt to taper CS in order to minimize CS dose (lowest
             feasible dose based on observed MG signs and symptoms)

        Exclusion Criteria:

          -  Any dose change in concomitant immunosuppressant therapy, other than CS, in the prior
             6 months

          -  Any change in CS dose or acetylcholinesterase inhibitor (e.g., pyridostigmine) dose in
             the 1 month prior to Screening

          -  A 3-point change in Quantitative Myasthenia Gravis score, increased or decreased,
             between the Screening/Week -3 (Visit 0) and Baseline (Week 0 [Visit 1])

          -  Any episode of myasthenic crisis (MC) in the 1 month prior to Screening, or (at any
             time in the past) MC or hospitalization for MG exacerbation associated with a previous
             CS taper attempt

          -  Evidence of malignancy within the past 5 years (non-melanoma skin cancer, carcinoma in
             situ of cervix is allowed) or thymoma potentially requiring surgical intervention
             during the course of the trial (intent to perform thymectomy)

          -  Thymectomy within the preceding 6 months prior to Screening

          -  Rituximab, belimumab, eculizumab or any monoclonal antibody used for immunomodulation
             within the past 12 months prior to Screening

          -  Have received immune globulin treatment given by IV, subcutaneous, or intramuscular
             route within the last 3 months prior to Screening

          -  Received plasma exchange performed within the last 3 months prior to Screening

          -  History of anaphylactic reactions or severe reactions to any blood-derived product

          -  History of recent (within the last year) myocardial infarction or stroke

          -  Uncontrolled congestive heart failure; embolism; or historically documented (within
             the last year) electrocardiogram changes indicative of myocardial ischemia or atrial
             fibrillation

          -  Current known hyperviscosity or hypercoagulable state

          -  Currently receiving anti-coagulation therapy. Oral anti-platelet agents are allowed
             (e.g., aspirin, clopidogrel, ticlopidine)

          -  Females of child-bearing potential who are pregnant, have a positive serum pregnancy
             test, breastfeeding, or are unwilling to practice a highly effective method of
             contraception throughout the study.

          -  Renal impairment

          -  Aspartate aminotransferase or alanine aminotransferase levels exceeding more than 2.5
             times the upper limit of normal for the expected normal range for the testing
             laboratory.

          -  Hemoglobin (Hb) levels &lt;9 g/dL
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rhonda Griffin, BSN</last_name>
    <email>Rhonda.Griffin@Grifols.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phoenix Neurological Associates, Ltd.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of California-Irvine</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veena Mathew</last_name>
    </contact>
    <investigator>
      <last_name>Tahseen Mozaffar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine, Department of Neurology</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joan Nye, BS</last_name>
    </contact>
    <investigator>
      <last_name>Richard Nowak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida at Shands Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christy Vickery</last_name>
    </contact>
    <investigator>
      <last_name>Michael Pulley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Harvey</last_name>
    </contact>
    <contact_backup>
      <last_name>Rita Tamcsu</last_name>
    </contact_backup>
    <investigator>
      <last_name>Tuan Vu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgia Regents University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandy Quarles</last_name>
    </contact>
    <investigator>
      <last_name>Michael Rivner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Guingrich</last_name>
    </contact>
    <contact_backup>
      <last_name>Angela Micheels</last_name>
    </contact_backup>
    <investigator>
      <last_name>Robert Pascuzzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center Research Institute, Inc.</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Johns</last_name>
    </contact>
    <investigator>
      <last_name>Mazen Dimachkie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers New Jersey Medical School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Reilly</last_name>
    </contact>
    <contact_backup>
      <last_name>Melody Furnari</last_name>
    </contact_backup>
    <investigator>
      <last_name>Nizar Souayah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allan Paras</last_name>
    </contact>
    <contact_backup>
      <last_name>Kim Arreum</last_name>
    </contact_backup>
    <investigator>
      <last_name>Thomas Brannagan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Beck</last_name>
    </contact>
    <contact_backup>
      <last_name>Lisa Gauger</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Guptill</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center, Neurology Department</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Agriesti</last_name>
    </contact>
    <investigator>
      <last_name>Miriam Freimer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Fedor</last_name>
    </contact>
    <investigator>
      <last_name>Marinos Dalakas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Neurological Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Lay, Jr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Lisa Thompson</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ericka Simpson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Lucy</last_name>
    </contact>
    <investigator>
      <last_name>Rup Tandan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Strom</last_name>
    </contact>
    <investigator>
      <last_name>Jane Distad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Tilkin</last_name>
    </contact>
    <investigator>
      <last_name>Philip Van Damme</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre- University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wilma Koopman</last_name>
    </contact>
    <contact_backup>
      <last_name>Denise Hulley</last_name>
    </contact_backup>
    <investigator>
      <last_name>Michael Nicolle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network (UHN) - Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Ng</last_name>
    </contact>
    <investigator>
      <last_name>Vera Bril</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de l'université de Montréal (CHUM) hospital Notre-Dame</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Montreal Neurological Institute Clinical Research Unit</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 2B4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Brno, Dept of Neurologicka klinika</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toncrova Stanislava</last_name>
    </contact>
    <investigator>
      <last_name>Josef Bednarik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Ostrava</name>
      <address>
        <city>Ostrava - Poruba</city>
        <zip>708 52</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milada Sedlakova</last_name>
    </contact>
    <investigator>
      <last_name>Petr Hon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vseobecna fakultni nemocnice v Praze, Dept of Neurologicka klinika</name>
      <address>
        <city>Praha 2</city>
        <zip>128 21</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iveta Novakova</last_name>
    </contact>
    <investigator>
      <last_name>Michaela Tyblova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Tallinn Central Hospital</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Raats</last_name>
    </contact>
    <investigator>
      <last_name>Toomas Toomsoo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg - Nouvel Hôpital Civil, Clinique Neurologique</name>
      <address>
        <city>Strasbourg cedex</city>
        <state>Bas Rhin</state>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Barun</last_name>
    </contact>
    <investigator>
      <last_name>Christine Tranchant</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse - Hôpital Purpan, Service de Neurologie Générale</name>
      <address>
        <city>Toulouse cedex 9</city>
        <state>Haute Garonne</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence Bucciarelli</last_name>
    </contact>
    <investigator>
      <last_name>David Brassat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Regensburg, Parent</name>
      <address>
        <city>Regensburg</city>
        <state>Bayern</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tina Kammermaier</last_name>
    </contact>
    <investigator>
      <last_name>Berthold Schalke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Giessen und Marburg GmbH Standort Marburg</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aysun Tan Celik</last_name>
    </contact>
    <investigator>
      <last_name>Bjoern Tackenberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsmedizin Goettingen, Parent</name>
      <address>
        <city>Göttingen</city>
        <state>Niedersachsen</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margret Schwarz</last_name>
    </contact>
    <investigator>
      <last_name>Jens Schmidt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Martha-Maria Halle-Doelau, Klinik fuer Neurologie</name>
      <address>
        <city>Halle</city>
        <state>Sachsen Anhalt</state>
        <zip>6120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Hochweld</last_name>
    </contact>
    <investigator>
      <last_name>Frank Hoffmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fachkrankenhaus Hubertusburg gGmbH, Klinik f. Neurologie</name>
      <address>
        <city>Wermsdorf</city>
        <state>Sachsen</state>
        <zip>4779</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Savvas Papadopoulos</last_name>
    </contact>
    <investigator>
      <last_name>Wolfgang Koehler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Jena, Klinik fuer Neurologie</name>
      <address>
        <city>Jena</city>
        <state>Thueringen</state>
        <zip>7747</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandy Arnold</last_name>
    </contact>
    <investigator>
      <last_name>Julian Grosskreutz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité Universitaetsmedizin Berlin, Klinik für Neurologie</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mechthild Schoenfeld</last_name>
    </contact>
    <investigator>
      <last_name>Andreas Meisel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Hamburg-Eppendorf, Klinik und Poliklinik</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dagmar Otto</last_name>
    </contact>
    <investigator>
      <last_name>Tim Magnus</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Neurologiai Osztaly</name>
      <address>
        <city>Budapest</city>
        <zip>1204</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klara Faust</last_name>
    </contact>
    <investigator>
      <last_name>Csilla Rozsa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pest Megyei Flor Ferenc Korhaz, Neurologia es Stroke Osztaly</name>
      <address>
        <city>Kistarcsa</city>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zita Biro</last_name>
    </contact>
    <investigator>
      <last_name>Gyula Panczel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Konyane</last_name>
    </contact>
    <investigator>
      <last_name>Laszlo Vecsei</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of Lithuanian University of Health Sciences Kaunas Clinics</name>
      <address>
        <city>Kaunas</city>
        <zip>50009</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renata Balnyte</last_name>
    </contact>
    <investigator>
      <last_name>Antanas Vaitkus</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uniwersyteckie Centrum Kliniczne, Dept of Neurology</name>
      <address>
        <city>Gdansk</city>
        <zip>80-952</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Kazmierska</last_name>
    </contact>
    <investigator>
      <last_name>Malgorzata Bilinska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krakowska Akademia Neurologii Sp z o.o. Centrum Neurologii Klinicznej</name>
      <address>
        <city>Krakow</city>
        <zip>31-505</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justina Wites</last_name>
    </contact>
    <investigator>
      <last_name>Andrzej Szczudlik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>III Szpital Miejski w Lodzi im. Dr K. Jonschera</name>
      <address>
        <city>Lodz</city>
        <zip>93-113</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paulina Budzinska</last_name>
    </contact>
    <investigator>
      <last_name>Tomasz Berkowicz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Centralny Szpital Kliniczny</name>
      <address>
        <city>Warszawa</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piotr Szczudlik</last_name>
    </contact>
    <investigator>
      <last_name>Anna Kostera-Pruszczyk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Lithuania</country>
    <country>Poland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2015</study_first_submitted>
  <study_first_submitted_qc>June 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2015</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Myasthenia Gravis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

